The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of the student body are women
students
locations
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
An Israeli medtech company whose novel therapy freezes and destroys malignant tumors has announced positive results in a trial of breast cancer patients. IceCure Medical’s ProSense system uses extremely cold liquid (cryoablation) to freeze and destroy abnormal tumors as an alternative to surgical removal. Its focus is currently on early-stage breast, lung, liver and kidney tumors. While cryoablation is not a new process, IceCure Medical’s system allows physicians to perform the procedure in their own offices, with no need for hospitalization. The company’s ICE3 study is the largest multicenter clinical trial performing cryoablation on low-risk and early-stage breast cancer tumors….
Pictured Above / L-R: Amir Livne, Dr. Gil Shamai and Prof. Ron Kimmel One in nine women globally will be diagnosed with breast cancer during their lifetime, and the numbers are only increasing as a result of factors, including increased lifespan and modern lifestyles. Personalized immunotherapy treatment is a necessity now more than ever, but the number of doctors and pathologists who specialize in examining tissue for specific diagnoses needed for personalized medicine is declining. To help combat this problem, Technion researchers have developed an artificial intelligence (AI) neural network that simplifies and improves the diagnostic process. Even better, the…
American Technion Society – New England Presents Boston Business Council Meeting With Maya Kaduri ’17, M.S.’19 and Dean Zadok ’19 In February 2022, ATS New England and the Boston Business Council joined forces for an interactive discussion with Maya Kaduri ’17, M.S.’19, a Ph.D. candidate in the Wolfson Faculty of Chemical Engineering, and Dean Zadok ’19, a master’s student […]
If the nervous system can help tumors grow, can it also do the reverse? Technion scientists had this in mind when they developed an innovative treatment for breast cancer based on targeting the nervous system with analgesic nanoparticles.
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.